Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Krzysztof Hoppe"'
Autor:
Anna Hoppe, Joanna Rupa-Matysek, Bartosz Małecki, Dominik Dytfeld, Krzysztof Hoppe, Lidia Gil
Publikováno v:
Medicina, Vol 57, Iss 10, p 1020 (2021)
Background and Objectives: Cancer associated thrombosis (CAT) is a common complication of neoplasms. Multiple myeloma (MM) carries one of the highest risks of CAT, especially in the early phases of treatment. Autologous stem cell transplantation (ASC
Externí odkaz:
https://doaj.org/article/1bc64089010141dbb6f73178fd6a8857
Autor:
Małgorzata Kałużna, Krzysztof Pawlaczyk, Krzysztof Schwermer, Krzysztof Hoppe, Aisha Yusuf Ibrahim, Magdalena Czlapka-Matyasik, Elżbieta Wrotkowska, Katarzyna Ziemnicka, Andrzej Oko, Marek Ruchała
Publikováno v:
Life, Vol 11, Iss 4, p 341 (2021)
Background: Preptin is a bone-anabolic pancreatic peptide hormone. Its role in bone metabolism has been studied in rats and in patients with diabetes, but its levels and significance in bone metabolism in hemodialyzed (HD) patients is unknown. Method
Externí odkaz:
https://doaj.org/article/c85c799f2336494fa2a2e5254346ec60
Autor:
Maria Wanic-Kossowska, Bartlomiej Posnik, Mikolaj Kobelski, Elzbieta Pawliczak, Krzysztof Pawlaczyk, Krzysztof Hoppe, Krzysztof Schwermer, Dorota Sikorska
Publikováno v:
The Scientific World Journal, Vol 2014 (2014)
Autosomal dominant polycystic kidney disease (ADPKD) is one of the most frequently occurring autosomal diseases inherited in the dominant manner. Due to this, lesions in the cardiovascular system of ADPKD patients have caught the attention of clinica
Externí odkaz:
https://doaj.org/article/f238637829a444edba308cb0ad9ea896
Autor:
Bartlomiej Posnik, Dorota Sikorska, Krzysztof Hoppe, Krzysztof Schwermer, Krzysztof Pawlaczyk, Andrzej Oko
Publikováno v:
Case Reports in Nephrology, Vol 2013 (2013)
Atypical hemolytic-uremic syndrome (aHUS), unlike typical HUS, is not due to bacteria but rather to an idiopathic or genetic cause that promotes dysregulation of the alternative complement pathway. It leads to hemolytic anemia, thrombocytopenia, and
Externí odkaz:
https://doaj.org/article/fc1e369963fe4afa93ec7b135e5d9220
Autor:
Krzysztof Hoppe, Krzysztof Schwermer, Mikołaj Dopierała, Małgorzata Kałużna, Anna Hoppe, Jadzia Tin-Tsen Chou, Andrzej Oko, Krzysztof Pawlaczyk
Publikováno v:
Nutrients, Vol 14, Iss 247, p 247 (2022)
Nutrients; Volume 14; Issue 2; Pages: 247
Nutrients
Nutrients; Volume 14; Issue 2; Pages: 247
Nutrients
Background: The population of end-stage renal disease (ESRD) patients with diabetes mellitus (DM) may be at increased risk of protein energy wasting (PEW). The aim of the study was to investigate the impact of DM on selected indicators of PEW in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::275a78d7edfd810170e8c4923c4620d4
https://www.mdpi.com/2072-6643/14/2/247
https://www.mdpi.com/2072-6643/14/2/247
Autor:
Krzysztof Schwermer, Katarzyna Ziemnicka, Małgorzata Kałużna, Nadia Sawicka-Gutaj, Aisha Yusuf Ibrahim, Magdalena Czlapka-Matyasik, Marek Ruchała, Andrzej Minczykowski, Andrzej Oko, Krzysztof Hoppe, Krzysztof Pawlaczyk
Publikováno v:
Advances in clinical and experimental medicine : official organ Wroclaw Medical University. 28(3)
Background The new polypeptide hormones adropin and irisin have a broad impact on human metabolism and energy homeostasis. They could be potential biomarkers of cardiac injury. In end-stage renal disease (ESRD), the clinical importance of adropin and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5184ae6777f3bfcaaa34fb02f4f05b60
https://pubmed.ncbi.nlm.nih.gov/30525316
https://pubmed.ncbi.nlm.nih.gov/30525316
Autor:
Bengt Lindholm, Dorota Radziszewska, Justin Nealis, Jolanta Kaczmarek, Krzysztof Schwermer, Ewa Baum, Patrycja Klysz, Małgorzata Kałużna, Peter Sawatiuk, Andrzej Oko, Krzysztof Hoppe, Krzysztof Pawlaczyk
Publikováno v:
Polish Archives of Internal Medicine. 125:560-569
INTRODUCTION N‑terminal pro‑B‑type natriuretic peptide (NT‑proBNP) is an established biomarker of heart failure in the general population. However, its diagnostic value is unclear in hemodialysis (HD) patients owing to renal insufficiency. OB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db6c09c1194428d5a48ee09d225c9a77
https://doi.org/10.20452/pamw.2969
https://doi.org/10.20452/pamw.2969
Autor:
Krzysztof Schwermer, Patrycja Klysz, Małgorzata Kałużna, Jolanta Kaczmarek, Krzysztof Pawlaczyk, Magdalena Roszak, Ewa Baum, Andrzej Oko, Peter Sawatiuk, Krzysztof Hoppe, Dorota Radziszewska, Bengt Lindholm
Publikováno v:
Blood Purification. 40:139-145
This study aimed to assess cardiac troponin T (cTnT) and hydration state as cardiovascular (CV) risk markers in hemodialysis (HD) patients. Two hundred and forty one patients were divided according to HD vintage into two groups: SV (HD ≤24 months)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b67c3288444c51ab97be3723652c2ca8
https://doi.org/10.1159/000376603
https://doi.org/10.1159/000376603
Autor:
Patrycja Klysz, Dorota Sikorska, Magdalena Roszak, Katarzyna Ścigacz, Anna Olewicz-Gawlik, Bengt Lindholm, Andrzej Oko, Krzysztof Hoppe, Anna Kawka, Krzysztof Schwermer, Ewa Baum, Krzysztof Pawlaczyk
Publikováno v:
Advances in clinical and experimental medicine : official organ Wroclaw Medical University. 26(2)
BACKGROUND Cardiovascular (CV) incidents are the major cause of mortality in maintenance dialysis (MD) patients undergoing peritoneal dialysis (PD) or hemodialysis (HD). CV injury indicators may be useful to investigate the dialysis modality influenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d7dfa41b2577d580b72593bf9c7b49a
https://pubmed.ncbi.nlm.nih.gov/28791842
https://pubmed.ncbi.nlm.nih.gov/28791842
Autor:
Andrzej Oko, Krzysztof Hoppe, Krzysztof Pawlaczyk, Dorota Sikorska, Bartlomiej Posnik, Krzysztof Schwermer
Publikováno v:
Case Reports in Nephrology, Vol 2013 (2013)
Case Reports in Nephrology
Case Reports in Nephrology
Atypical hemolytic-uremic syndrome (aHUS), unlike typical HUS, is not due to bacteria but rather to an idiopathic or genetic cause that promotes dysregulation of the alternative complement pathway. It leads to hemolytic anemia, thrombocytopenia, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c53f30f63b62cd46471173dcb9c82ca
https://doi.org/10.1155/2013/739820
https://doi.org/10.1155/2013/739820